Gilead Sciences Canada, Inc. / Jennifer Anthony, Consultant Lobbyist - Registration - Consultant Lobbyist - Lobbyists Registry - Office of the Registrar or Lobbying of BC

This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.

Registration ID: 50064204
Submitted by lobbyist on: July 24, 2019 03:11:14 PM
Accepted by Registrar on: July 25, 2019 08:47:14 AM

Lobbyist Information

Name: Anthony, Jennifer

Contact Information: 777 Hornby Street, 16th Floor
Vancouver, BC, V6Z 2T3	604-630-0393
Canada

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbyist Firm Information

Name: FleishmanHillard HighRoad Corp

Firm Contact Information: 777 Hornby Street, 16th Floor
Vancouver, BC, V6Z 2T3	604-630-0393
Canada

Client Information

Name: Gilead Sciences Canada, Inc.

Business Activities:

Gilead develops and produces life-saving therapies, including Yescarta, which was recently approved in Canada for treatment of non-Hodgkin lymphoma.

Contact Information: 6711 Mississauga Road, Suite 6
Mississauga, ON, L5N 2W3	905-363-8008
Canada

Relevant Affiliates

The client has no relevant affiliates.

Government or Government Agency Funding

The organization does not receive any funding from a government or government agency.

Other Controlling or Directing Interests

The organization has no other controlling or directing interests.

Undertaking Information

Undertaking Start Date: July 24, 2019
Undertaking End Date: December 31, 2020

There are no other individuals engaged to lobby on this undertaking.

Lobbying Activities

Health

Arranging meeting between an individual and a public office holder

I have been asked to arrange meetings between my client, Gilead Sciences, and public office holders for the purpose of informing them about recent advances in CAR T therapies, including Gilead therapy, Yescarta. Gilead develops and produces life-saving therapies, including Yescarta, which was recently approved in Canada for treatment of non-Hodgkin lymphoma.

Target Contacts

Target Type	Name	Title or Constituency	Date Added
Minister	Dix, Adrian	Minister of Health	July 24, 2019
Minister	James, Carole	Minister of Finance	July 24, 2019
Minister	Mark, Melanie	Minister of Advanced Education, Skills and Training	July 24, 2019
Minister	Robinson, Selina	Minister of Municipal Affairs and Housing	July 24, 2019
MLA	Brar, Jagrup	Surrey-Fleetwood	July 24, 2019
MLA	Kahlon, Ravi	Delta North	July 24, 2019
MLA	Letnick, Norm	Kelowna-Lake Country	July 24, 2019
MLA	Shypitka, Tom	Kootenay East	July 24, 2019
Public Agency	Health		July 24, 2019